Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/7/2023
WuXi XDC Eyes Up to $471M in Hong Kong IPO
11/1/2023
Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
10/17/2023
China: The New Frontier for Western CDMOs? (Contract Pharma)
9/28/2023
Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...
9/26/2023
China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...
9/26/2023
WuXi Debuts First Vaccine CDMO Site in China
9/24/2023
Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...
9/24/2023
PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...
9/18/2023
GenScript Expands Range of Reagent Services, Adding Circular RNA and L...
8/16/2023
Biocytogen Pharma Announces Opening of Waltham, MA Facility
8/15/2023
Aurisco Pharma's Plant in Yangzhou Passes USFDA Inspection
7/28/2023
WuXi Vaccines' First Chinese Drug Substance Facility Released for GMP ...
7/17/2023
WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturin...
7/10/2023
WuXi Biologics Announces Proposed Spin-off and Separate Listing of WuX...
5/17/2023
WuXi Bio Enters Manufacturing Partnership with InflaRx to Advance Gohi...
5/10/2023
Cytoniche Biotech Opens Center of Excellence in China
5/9/2023
Aurisco and Cytiva to Build Its First Oligo FlexFactory for Commercial...
4/19/2023
Crystal Pharmatech's CDMO BU Receives China Drug Product Manufacturing...
4/5/2023
WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Conti...
4/5/2023
Pharmaron Plans UK Gene Therapy Expansion
1/5/2023
GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
1/5/2023
Aurisco to Build Oligonucleotides Manufacturing Facility in China
12/2/2022
China's Challenge in the Drug Services Field (C&EN)
11/30/2022
WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...
11/23/2022
WuXi AppTec Begins Construction of Wuxi STA's East China R&D Facility
10/26/2022
WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...
10/20/2022
IQVIA Forecasts Chinese CMDO Market to Grow 20% CAGR Before 2025
10/19/2022
Fitch: US Biomanufacturing Plan Poses Minor Risks to Chinese Pharma CD...
10/8/2022
U.S. Adds 31 Additional Chinese Cos to Unverified List, But Removing A...
9/28/2022
Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou
Page:
2
/
16
Total number of articles:
466
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit